IGF1 and early-onset autosomal dominant Alzheimer disease: In particular, IGF/IGF-IR-independent actions of IGFBP3 have been shown to contribute to the pathophysiology of a variety of human diseases, such as cancer, diabetes, and Alzheimer’s disease [27].